At a glance
ClinicalIndex Comparison RecordN/ACompleted· 70 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Vulvovaginal Graft Versus Host Disease in Women Who Underwent Transplantation Before and After Menarche
In Brief
An observational study for Graft-vs-Host Disease. Completed, enrolled 70 participants across 2 sites.
Detailed Summary
The study will evaluate the prevalence and characteristics of vulvovaginal graft versus host disease (VV- GVHD) in patients who underwent hematopoietic stem cell transplantation (HSCT) as girls or adolescents and will compare the prevalence, characteristics and severity of VV-GVHD before and after menarche.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGraft-vs-Host Disease
CountriesIsrael
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedJan 2012
Enrollment StartDec 2012
Primary CompletionDec 2018
TodayJul 2026
First PostedJan 19, 2012
Enrollment StartDec 1, 2012
Primary CompletionDec 1, 2018
TodayJul 2, 2026
Enrollment to primary: 6 yearsPosted 14.5 years ago